In vitro search for synergy and antagonism: Evaluation of docetaxel combinations in breast cancer cell lines

Breast Cancer Research and Treatment

Volumn 74, Issue 1, 2002, Pages 41-46

  Budman, Daniel R ^a   Calabro, Anthony ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast cancer; Cell lines; Docetaxel; Median effect analysis; Synergism

Indexed keywords

ALITRETINOIN; DEXAMETHASONE; DISULFIRAM; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GLUTATHIONE TRANSFERASE; MELPHALAN; MULTIDRUG RESISTANCE PROTEIN 1; NAVELBINE; PACLITAXEL; RAZOXANE; VALSPODAR; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DRUG DERIVATIVE; ENZYME INHIBITOR; RETINOIC ACID; TAXOID; VINBLASTINE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; BREAST TUMOR; CELL CULTURE; DRUG INTERACTION; DRUG SCREENING; FEMALE; PATHOLOGY;

ANTIBIOTICS, ANTHRACYCLINE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DISULFIRAM; DRUG INTERACTIONS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; EPIRUBICIN; FEMALE; HUMAN; PACLITAXEL; RAZOXANE; SUPPORT, NON-U.S. GOV'T; TRETINOIN; TUMOR CELLS, CULTURED; VINBLASTINE; ANTIBIOTICS, ANTINEOPLASTIC; HUMANS; TAXOIDS;

EID: 0035988004     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016070230538     Document Type: Article

References (47)

1. Interaction between gemcitabine and mitomycin-C in vitro
2. In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agents
3. Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines
4. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: Induction of synergistic cytotoxicity independent of reversal of apoptosis resistance
5. Three-drug combination of MKC-442, lamivudine and zidovudine in vitro: Potential approach towards effective chemotherapy against HIV-1
6. In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines
7. Synergistic interaction between dehydroepiandrosterone and prednisolone in the inhibition of rat lymphocyte proliferation
8. Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines
9. Quantitation of the synergistic interaction of edatrexate and cisplatin in vitro
10. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro
11. Enhancement of trimetrexate cytotoxicity in vitro and in vivo by carboxypeptidase G2
12. Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro
13. A phase I study of sequential vinorelbine followed by paclitaxel
14. Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell lines
15. Daily oral estramustine and intermittant intravenous docetaxel (taxotere) as chemotherapeutic treatment for metastatic, hormone-refractory prostate cancer
16. Docetaxel and paclitaxel in breast cancer therapy: Present status and future prospects
17. Taxol (paclitaxel): A novel anti-microtubule agent with remarkable anti-neoplastic activity
18. Current status of Taxotere (docetaxel) as a new treatment in breast cancer
19. Putting taxanes to work in operable breast cancer: A search for selective indications from empirical studies
20. Taxanes in the treatment of breast cancer: A prodigy comes of age
21. Paclitaxel (taxol) and docetaxel (taxotere): Not simply two of a kind
22. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
23. Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism
24. Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp)
25. All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cell lines in vitro
26. Isolation of two human tumor epithelial cell lines from solid breast carcinomas
27. Anti-estrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells
28. Evaluation of three established cell lines derived from patients with prostate cancer (DU 145. PC-3, LnCaP) for phenotype and sensitivity to doxorubicin and vinblastine with or without the new cyclosporin D derivative PSC 833
29. Computerized quantietation of synergism and antagonism of taxol, topotecan, and cisplatin, against human teratocarcinoma cell growth: A rational approach to clinical protocol design
30. Generalized equations for the analysis of inhibitions of Michaelis-Menton and higher order kinetic systems with two or more mutually exclusive and non-exclusive inhibitors
31. Disulfiram is a potent inhibitor of proteases of the caspase family
32. The pharmacology and toxicology of disulfiram and its metabolites
33. Overview and historical development of dexrazoxane
34. Clinical trials of bis-dioxopiperazine propane (ICRF 159; NSC 129,943) in acute leukaemias
35. Doxorubicin cardiotoxicity and serum lipid increase is prevented by dextrazoxane (ICRF-187)
36. Dexrazoxane (ICRF-187)
37. Reduction by ICRF-187 of acute daunorubicin toxicity in Syrian golden hamsters
38. Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemias
39. Potentiation of doxorubicin cytotoxicity by (+)-1,2-bis-(3,5-dioxopiperazinyl-1-yl) propane (ICRF-187) in human leukemia HL-60 cells
40. A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines
41. Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukemia line, K562
42. In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: Time to consider expanded clinical trials?
43. Docetaxel in combination with doxorubicin or vinorelbine
44. Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor
45. A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer
46. Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer
47. Effects of trans-retinoic acid, 9-cis-retinoic acid, 1alpha, 25-(dihydroxy)-vitamin D3 and a novel apoptosis-inducing retinoid on breast cancer and endothelial cell growth